Skip to main content

Table 1 Univariate analyses of prognostic factors for OS of stage III gastric cancer

From: Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer

Variables

5-year OS (%)

No. of patients

Univariate

n

%

HR (95% CI)

p value

Total

48.7

225

100

  

Age (years)

  ≤ 68

54.0

117

52.0

1

 

  > 68

42.8

108

48.0

1.643 (1.164–2.319)

0.005

Sex

 Male

47.3

147

65.3

1

 

 Female

51.2

78

34.7

1.188 (0.823–1.715)

0.357

BMI (kg/m2)

 Low (≤ 21.9)

46.7

114

50.7

1

 

 High (>  21.9)

50.6

111

49.3

0.950 (0.674–1.339)

0.771

Performance status

 0

52.1

167

74.2

1

 

 1–3

39.1

58

25.8

1.606 (1.109–2.325)

0.012

Location

 Upper/Middle/Lower

50.7

209

92.9

1

 

 Whole

20.6

16

7.1

1.334 (1.092–1.630)

0.005

Macroscopic type

 Type 0/1/2

56.9

61

27.1

1

 

 Type 3/4/5

45.6

164

72.9

1.145 (0.774–1.693)

0.497

Operative procedure

 Distal gastrectomy

59.7

117

52.0

1

 

 Total gastrectomy

36.9

108

48.0

1.835 (1.295–2.600)

0.001

Lymph node dissection

 D1

49.8

32

14.2

1

 

 D2

48.6

193

85.8

0.911 (0.553–1.500)

0.713

Histology

 Differentiated

54.0

97

43.1

1

 

 Undifferentiated

44.4

128

56.9

1.198 (0.846–1.697)

0.308

Lymphatic invasion

 Absent

57.9

19

8.4

1

 

 Present

47.8

206

91.6

1.174 (0.633–2.177)

0.611

Venous invasion

 Absent

50.3

156

69.3

1

 

 Present

44.8

69

30.7

1.193 (0.830–1.716)

0.340

TNM sub-stage

 IIIA

62.2

80

35.6

1

0.011

 IIIB

45.4

72

32.0

1.579 (1.030–2.420)

0.036

 IIIC

36.2

73

32.4

1.908 (1.242–2.931)

0.003

Tumor size (mm)

  ≤ 60

55.9

115

51.1

1

 

  > 60

40.9

110

48.9

1.534 (1.086–2.166)

0.015

Adjuvant chemotherapy

 Absent

40.1

41

18.2

1

 

 Present

50.6

184

81.8

0.575 (0.382–0.865)

0.008

CAR

 Low (≤ 0.47)

50.6

211

93.8

1

 

 High (>  0.47)

21.4

14

6.2

2.844 (1.561–5.181)

0.001

NLR

 Low (≤ 1.90)

58.0

99

44.0

1

 

 High (>  1.90)

41.2

126

56.0

1.400 (0.986–1.988)

0.060

PLR

 Low (≤ 172)

53.2

141

62.7

1

 

 High (>  172)

40.9

84

37.3

1.376 (0.970–1.953)

0.074

PNI

 Low (≤ 45.6)

39.0

90

40.0

1

 

 High (>  45.6)

54.9

135

60.0

0.730 (0.517–1.031)

0.074

GPS

 0

51.1

171

76.0

1

 

 1/2

41.1

54

24.0

1.463 (0.992–2.156)

0.055

PI

 0

50.1

205

91.1

1

 

 1/2

35.0

20

8.9

1.592 (0.914–2.773)

0.101

  1. BMI body mass index, PS performance status, TNM tumor-node-metastasis, CAR C-reactive protein/Albumin ratio, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, PNI Prognostic Nutritional Index, GPS Glasgow Prognostic Score, PI prognostic index